Comirnaty JN.1 10 μg, Injektionsdispersion
7680699120024
CH-69912
Injektionsdispersion
Associated product:
COMIRNATY JN.1 émuls inj 10 mcg/dose vial 10 pce
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionsdispersion
- Galenic group
- Unknown
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
bretovameranum
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas)
|
- | Substance | HNIDK |
|
2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum
|
- | Substance | HNIDK |
|
1,2-distearoyl-sn-glycero-3-phosphocholinum
|
- | Substance | HNIDK |
|
cholesterolum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
trometamolum
|
- | Substance | HNIDK |
|
trometamoli hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69912
- Drug name
- Comirnaty JN.1, Injektionsdispersion
- Galenic form
- DISIJ
- ATC Code
- J07BN01
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- B
- First authorization
- 12/08/2024
- Authorization expiration date
- 17/01/2026
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- COMIRNATY JN.1 émuls inj 10 mcg/dose vial 10 pce
- Description (DE)
- COMIRNATY JN.1 Inj Emuls 10 mcg/Dosis Vial 10 Stk
- Market launch
- 21/08/2024
- Market withdrawal
- 17/01/2026
- Narcotic (BTM)
- No
Other package sizes (1)
COMIRNATY JN.1 émuls inj 30 mcg/dose vial 10 pce
10 DUR
GTIN: 7680699120017